An open pilot study using tacrolimus ointment in the treatment of seborrheic dermatitis

Journal of the American Academy of Dermatology

Volumn 49, Issue 1, 2003, Pages 145-147

  Meshkinpour, Azin ^b   Sun, Joannie ^b   Weinstein, Gerald ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; DRUG WITHDRAWAL; DRY SKIN; FEMALE; FLUSHING; HUMAN; MALASSEZIA FURFUR; MALE; OINTMENT; PILOT STUDY; PRIORITY JOURNAL; SEBORRHEIC DERMATITIS; SKIN IRRITATION;

EID: 0038723737     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2003.450     Document Type: Article

References (18)

1. Nghiem P. "Tropical immunomodulators?" Introducing old friends and new ally, tacrolimus. J Am Acad Dermatol 2001;44: 111-3.
2. Tofte SJ, Hanifin JM. Current management and therapy of atopic dermatitis. J Am Acad Dermatol 2001;44(Suppl):513-6.
3. Assmann T, Homey B, Ruzicka T. Topical tacrolimus for the treatment of inflammatory skin diseases. Expert Opin Pharmacother 2001;2:1167-75.
4. Gianni LM, Sulli MM. Topical tacrolimus in the treatment of atopic dermatitis. Ann Pharmacother 2001;35:943-6.
5. Faergemann J. Seborrhoeic dermatitis and Pityrosporum orbiculare: treatment of seborrhoeic dermatitis of the scalp with miconazole-hydrocortisone (Daktacort), micaonazole and hydrocortisone. Br J Dermatol 1986;114:695-700.
6. Bergbrant I-M. Seborrheic dermatitis and Pityrosporum ovale: cultural, immunological and clinical studies. Acta Derm Venereol Suppl (Stockh) 1991;167:1-36.
7. Faergemann J, Bergbrant I-M, Dohse M, Scott A, Westgate G. Seborrheic dermatitis and Pityrosporum (Malassezia) folliculitis: characterization of inflammatory cells and mediators in the skin by immunohistochemistry. Br J Dermatol 2001;144:549-56.
8. Faergemann J. Pityrosporum species as a cause of allergy and infection. Allergy 1999;54:413-9.
9. Watanabe S, Kano R, Sato H, Nakamura Y, Hasegawa A. The effects of Malassezia yeasts on cytokine production by human keratinocytes. J Invest Dermatol 2001;116:769-73.
10. Parry ME, Sharpe GR. Seborrhoeic dermatitis is not caused by an altered immune response to Malassezia yeast. Br J Dermatol 1998;139:254-63.
11. Bos JD, Smitt JHS. Atopic dermatitis. J Eur Acad Dermatol Venereol 1996;7:101-14.
12. Lemster BH, Carroll PB, Rilo HR, Johnson N, Nikaein A, Thomson AW. IL-8/IL-8 receptor expression psoriasis response systemic tacrolimus (FK506). Clin Exp Immunol 1995;99:148-54.
13. Mori A, Suko M, Nishizaki Y, Kaminuma O, Matsuzaki G, Etoh T, et al. Regulation of interleukin-5 production by peripheral blood mononuclear cells from atopic patients with FK506, cyclosporin A and glucocorticoids. Int Arch Allergy Immunol 1994;104:32-5.
14. Nakagawa H, Etoh T, Ishibashi Y, Higaki Y, Kawashima M, Torii H, et al. Tacrolimus ointment for atopic eczema. Lancet 1994;344: 883.
15. Assman T, Homey B, Ruzicka T. Applications of tacrolimus for the treatment of skin disorders. Immunopharmacology 2000;47: 203-13.
16. Ruzicka T, Bieber T, Schopf E, Rubins A, Dobozy A, Bos JD, et al. A short-term trial of tacrolimus ointment for atopic dermatitis. N Engl J Med 1997;337:816-21.
17. Sengoku T, Morita K, Sato S, Sakuma S, Ogawa T, Hiroi J, et al. Effects of tacrolimus ointment on type I (immediate and late) and IV (delayed) cutaneous allergic reactions in mice. Folia Pharmacol Jpn 1998;112:221-32.
18. Meingassner JG, Stutz A, Immunosuppressive macrolides of the type FK506: a novel class of topical agents for treatment of skin diseases? J Invest Dermatol 1992;98:851-5.